Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

P16410 (CTLA4_HUMAN) Homo sapiens (Human)

Cytotoxic T-lymphocyte protein 4 UniProtKBInterProSTRINGInteractive Modelling

223 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5); 4 identical sequences: Pan troglodytes: A0A2I3SUF9, A0A6D2W8G9; Pan paniscus: A0A2R9CI29; Gorilla gorilla gorilla: G3QY54

Available Structures

20 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Engineered Human Lipocalin 2 (LCN2) in Complex with the Extracellular Domain of Human CTLA-4 Heteromer
38-157
Assess
Crystal structure of anti-CTLA-4 humanized IgG1 MAb--JS007 in complex with human CTLA-4 Heteromer
35-154
Assess
CTLA-4 in complex with tremelimumab Fab Heteromer
36-154
Assess
HUMAN B7-1/CTLA-4 CO-STIMULATORY COMPLEX Heteromer
P33681;
38-155
NAG;MAN;
Assess
CRYSTAL STRUCTURE OF THE CTLA-4/B7-2 COMPLEX Heteromer
P42081;
38-155
Assess
A Non-blocking anti-CTLA-4 Nanobody complexed with CTLA-4 Heteromer
38-155
NAG;NAG;NA;
Assess
The crystal structure of CTLA-4 and Fab Heteromer
36-152
Assess
Crystal structure of anti-CTLA-4 VH domain in complex with human CTLA-4 Heteromer
37-153
EDO;
Assess
Crystal structure of an acidic pH-selective Ipilimumab variant Ipi.105 in complex with CTLA-4 Heteromer
37-153
NAG;
Assess
Crystal structure of CTLA-4 complexed with the Fab of HL32 antibody Heteromer
38-154
NAG;
Assess
Structure of the first-in-class checkpoint inhibitor Ipilimumab bound to human CTLA-4 Heteromer
37-152
Assess
A blocking anti-CTLA-4 Nanobody (KN044) complexed with CTLA-4 Heteromer
39-154
Assess
Crystal structure of an acidic pH-selective Ipilimumab variant Ipi.106 in complex with CTLA-4 Heteromer
37-151
NAG;
Assess
Crystal Structure of Ipilimumab Fab complexed with CTLA-4 at 2.6A resolution Heteromer
38-152
Assess
MU2 ADAPTIN SUBUNIT (AP50) OF AP2 ADAPTOR (SECOND DOMAIN), COMPLEXED WITH CTLA-4 INTERNALIZATION PE… Heteromer
Q96CW1;
197-206
Assess
Molecular interactions of cytoplasmic region of CTLA-4 with SH2 domains of PI3-kinase Heteromer
P27986;
199-206
Assess
Crystal structure of human CTLA-4 apo homodimerhomo-2-mer38-160
NAG;GOL;
Assess
Structure of a strand-swapped dimeric form of CTLA-4homo-2-mer36-155
Assess
CTLA-4, NMR, 20 STRUCTURESmonomer37-161
NAG;NAG;
Assess
Complex structure of ipilimumab-scFv and CTLA-4monomer36-154
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3osk.1.Bmonomer0.7938-160
100.00
Assess
2x44.1.Amonomer0.7036-155
97.66
Assess

2 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 57elx.2.Cmonomer0.8036-152
94.44
Assess
Isoform 52x44.1.Amonomer0.7236-155
92.97
Assess